Ultragenyx Pharmaceutical | RARE - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical reported $218.18M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 224.3M 98.67M
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Alnylam Pharmaceuticals ALNY:US USD 673.39M 94.52M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Bluebird Bio BLUE:US USD 115.93M 12.3M
Esperion Therapeutics ESPR:US USD 95.49M 3.18M
Immunic Inc. VTL:US USD 16.3M 3.22M
Insmed INSM:US USD 187.98M 2.26M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Karyopharm Therapeutics KPTI:US USD 61.56M 10.45M
Kyowa Hakko Kirin 4151:JP JPY 101.09B 8.74B
MacroGenics MGNX:US USD 45.61M 3M
Mirati Therapeutics MRTX:US USD 124.6M 34.85M
Moderna Inc MRNA:US USD 3.5B 1.42B
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
PTC Therapeutics PTCT:US USD 441.63M 35.4M
Puma Biotechnology PBYI:US USD 48.19M 29.3M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Sarepta Therapeutics SRPT:US USD 536.88M 82.72M
Ultragenyx Pharmaceutical RARE:US USD 218.18M 43.03M
Vertex Pharmaceuticals VRTX:US USD 3.03B 284.1M